CANF

CANF

USD

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

$1.130-0.035 (-3.038%)

वास्तविक समय मूल्य

Healthcare
जैव प्रौद्योगिकी
इज़राइल

मूल्य चार्ट

मुख्य मीट्रिक्स

बाजार मीट्रिक्स
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े

बाजार मीट्रिक्स

खुलना

$1.165

उच्च

$1.170

कम

$1.130

मात्रा

0.01M

कंपनी के मौलिक सिद्धांत

बाजार पूंजीकरण

15.8M

उद्योग

जैव प्रौद्योगिकी

देश

Israel

ट्रेडिंग आँकड़े

औसत मात्रा

0.29M

एक्सचेंज

ASE

मुद्रा

USD

52-सप्ताह रेंज

कम $1.13वर्तमान $1.130उच्च $4.69

संबंधित समाचार

GlobeNewswire

Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite's Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients

Ramat Gan, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and

और देखें
Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite's Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients
Analyst Upgrades

D. Boral Capital Maintains Buy on Can Fite Biofarma, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains Can Fite Biofarma with a Buy and maintains $10 price target.

और देखें
D. Boral Capital Maintains Buy on Can Fite Biofarma, Maintains $10 Price Target
GlobeNewswire

Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares

RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory

और देखें
Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares
GlobeNewswire

Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships

Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory

और देखें
Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
GlobeNewswire

Can-Fite Reports 2024 Financial Results and Clinical Update

RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and

और देखें
Can-Fite Reports 2024 Financial Results and Clinical Update

अपडेट रहें

मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।